MAP2 and early-onset autosomal dominant Alzheimer disease: Depletion of MAP2 has been associated with a Lewy body variant of Alzheimer’s disease [16], whereas colocalization of MAP2 with α-synuclein in Lewy bodies was shown in Parkinson’s disease [17].